A broader set of medications producing 20% or greater savings. Use the tabs to compare each trust independently.
| Medication | Claims | Plan Cost | Member Savings | Plan Savings | Savings % | Required Rebate to Match | Can PBM Match? | Savings Status |
|---|---|---|---|---|---|---|---|---|
| Skyrizi | 44 | $212,762 | $7,500 | $52,582 | 24.7% | 24.7% | POSSIBLY | ≈ Rebate |
| Kisqali (600 MG Dose) | 32 | $199,544 | $19,516 | $48,173 | 24.1% | 24.1% | UNLIKELY | Moderate |
| Kisqali (400 MG Dose) | 34 | $145,277 | $13,001 | $37,506 | 25.8% | 25.8% | UNLIKELY | Moderate |
| Entyvio Pen | 24 | $58,532 | $5,885 | $15,569 | 26.6% | 26.6% | UNLIKELY | Moderate |
| Descovy | 23 | $43,966 | $0 | $12,332 | 28.1% | 28.1% | UNLIKELY | Moderate |
| Nurtec | 45 | $18,945 | $5,472 | $5,485 | 28.9% | 28.9% | UNLIKELY | Moderate |
| Ubrelvy | 35 | $12,767 | $3,715 | $2,925 | 22.9% | 22.9% | UNLIKELY | Moderate |
| Orilissa | 8 | $8,770 | $640 | $2,036 | 23.2% | 23.2% | UNLIKELY | Moderate |
| Breo Ellipta | 14 | $3,735 | $1,008 | $1,050 | 28.1% | 28.1% | UNLIKELY | Moderate |
| Rasuvo | 16 | $3,065 | $748 | $889 | 29.0% | 29.0% | UNLIKELY | Moderate |
| Spiriva Respimat | 12 | $1,330 | $716 | $358 | 26.9% | 26.9% | UNLIKELY | Moderate |
Showing only medications with savings between 20% and 29%. The "Required Rebate to Match" column shows the manufacturer rebate percentage a traditional PBM would need to deliver to equal RxProtect's savings on that medication.